Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Find out which savings strategy is most effective for your financial goals. Implement these strategies for better savings.
26,213 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A crypto-focused venture outfit scores a $1.2 billion fund rise, signaling a major shift toward AI and robotics along...
Palantir trades near the $150 level amid volatility. This guide breaks down whether palantir technologies stock no-br...
In a volatile start to 2026, investors are seeking dividend ETFs built survive strategies that combine durable income...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
Pershing Square’s bill ackman been quietly building a Microsoft stake since February signals a patient, long-term bet...
A long-running dividend ETF marks 22 years of payments as retirees continue to seek steady income in a shifting marke...
SpaceX is entering the IPO spotlight, but valuing a space, AI, and satellite powerhouse is unique. This guide breaks ...
SoFi stock has faced a meaningful hurdle in 2026. This guide breaks down whether the decline represents a temporary s...
Ripple wins preliminary approval to operate under MiCA in Luxembourg, but the path to a full MiCA license is far from...
PepsiCo trims snack prices in North America to spur demand, but the pause in regional growth keeps investors focused ...
As markets swing into February 2026, a core group of performing cash stocks on Cash App are leading gains. This repor...